AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area’s buzzy Oyster Point
AbbVie has signed on to be the first tenant of a massive new research center in Oyster Point, joining a flock of biopharma peers that’s set up shop in the increasingly popular South San Francisco neighborhood.